David Moher
Statistics and Probability · 2001–2025
A researcher in the Science corpus: 90 papers; trusts 67 researchers and is trusted by 315 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 730 citations into it; #177 of 13,188 by trust here, #6 by citations
- Economics and Econometrics — 285 citations into it; #750 of 23,545 by trust here, #54 by citations
- General Health Professions — 273 citations into it; #42 of 4,786 by trust here, #5 by citations
- Public Health, Environmental and Occupational Health — 176 citations into it; #11 of 2,377 by trust here, #2 by citations
- Sociology and Political Science — 149 citations into it; #8,088 of 22,891 by trust here, #182 by citations
- Pharmacology — 78 citations into it; #815 of 1,115 by trust here, #40 by citations
- Molecular Biology — 72 citations into it
- Surgery — 64 citations into it; #543 of 1,109 by trust here, #13 by citations
Whom David Moher trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Douglas G. Altman
- K. F. Schulz
- A. Liberati
- Sander Greenland
- E. von Elm
- Matthias Egger
- John P. A. Ioannidis
- J. Tetzlaff
- Diana Elbourne
- A. Chan
Who trusts David Moher overall
- Douglas G. Altman
- K. F. Schulz
- Matthew J. Page
- Stanley E. Lazic
- Gunther Eysenbach
- Myron D. Ginsberg
- Lisa M. McShane
- Blend Ibrahim
- I. Boutron
- J. McKenzie
Papers from David Moher's perspective
Ordered by how strongly the researchers David Moher trusts endorse each paper. Same corpus, a different order for every researcher.
- Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
- Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
- Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (International Journal of Surgery)
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (PLoS Medicine)
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (British medical journal)
- What is missing from descriptions of treatment in trials and reviews? (British medical journal)
- External validity of randomised controlled trials: "to whom do the results of this trial apply?".
Their papers
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001) — 3,977 citations
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) — 6,841 citations
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009) — 126,097 citations
- Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (2006) — 864 citations
- Guidance for Developers of Health Research Reporting Guidelines (2010) — 1,230 citations
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) — 37,422 citations
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (2008) — 615 citations
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2010) — 8,251 citations
- Reducing waste from incomplete or unusable reports of biomedical research. (2014) — 1,136 citations
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001) — 3,748 citations
- Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. (2012) — 633 citations
- Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004) — 1,406 citations
- Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (2008) — 2,305 citations
- Addressing Reporting Biases (2008) — 720 citations
- The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. (2003) — 791 citations
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (2001) — 2,226 citations
- Improving the reporting of pragmatic trials: an extension of the CONSORT statement (2008) — 1,746 citations
- Epidemiology and Reporting Characteristics of Systematic Reviews (2007) — 843 citations
- The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration (2003) — 1,546 citations
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviews (2012) — 1,395 citations